Frank joined GroveStreet in 2001 and is a member of the firm’s Investment Committee. He leads investments across all segments of private equity and offers particular expertise in healthcare venture capital, mid-sized European buyouts and energy-focused private equity funds. He is a member of a number of fund advisory boards and works closely with clients on developing portfolio construction models and forecasting tools. Frank has served as a Visiting Executive at Harvard Business School, as a guest lecturer in the MBA class Venture Capital and Private Equity.Prior to joining GroveStreet, Frank was a Co-founder of Biocode Inc., a venture-backed biotech startup where he helped raise $15 million in venture capital over three rounds of financing. During his six-year tenure at Biocode, Frank held a number of executive roles, including 18 months as Managing Director, Asia, based in Singapore, and was a co-inventor on two patents. Previously, Frank spent three years in early-stage venture capital as an associate at Innotage Management and as an analyst in the healthcare group of Advent Venture Partners in London.Frank earned an MBA from Harvard Business School (Baker Scholar) and a BA, Interdisciplinary Studies, from the University of Virginia.